CDK4 amplification has been observed in several malignancies including glioma, breast cancer, and lung cancer [24], and an absence of CDK4 amplification in WD and DD liposarcomas is associated with lower rate of recurrence and favorable prognosis [47]. This evidence concerns the gene CDK4 and liposarcoma.